Kilitch Drugs (India) Limited (NSE:KILITCH)

India · Delayed Price · Currency is INR

189.00

+6.73 (3.69%)

May 25, 2026, 11:17 AM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Development and Operations of Pharmaceutical Business	2.35B	1.98B	1.54B	1.40B	1.14B
Development and Operations of Pharmaceutical Business Growth	18.74%	28.47%	10.58%	22.20%	66.71%
Total	2.35B	1.98B	1.54B	1.40B	1.14B
Total Growth	18.74%	28.47%	10.58%	22.20%	66.71%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
India	862.49M	706.43M	567.76M	413.34M
India Growth	22.09%	24.42%	37.36%	75.01%
Export	1.11B	829.63M	820.82M	716.25M
Export Growth	33.78%	1.07%	14.60%	60.34%
Unallocated	10.79M	7.66M	7.41M	12.76M
Unallocated Growth	40.77%	3.44%	-41.93%	446.15%
Total	1.98B	1.54B	1.40B	1.14B
Total Growth	28.47%	10.58%	22.20%	66.71%

Source: S&P Global Market Intelligence.